Next day disclosure return
Filed with HKEX · Stock code 2652 · · 6 pages · English
Earlier from CF PharmTech
- 2026 Interim Report
- Voluntary announcement ICF004 completes enrolment and dosing of first healthy volunteer in phase i clinical trial
- List of Directors and their Roles and Functions
- Change in board lot size
Later from CF PharmTech
- Voluntary announcement voluntary extension of lock-up period for shares held by core management by six months
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Follow CF PharmTech into a list and get an email when it puts out news.
Follow CF PharmTech